Unique ID issued by UMIN | UMIN000004385 |
---|---|
Receipt number | R000005217 |
Scientific Title | Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancer |
Date of disclosure of the study information | 2010/10/14 |
Last modified on | 2011/11/15 14:55:58 |
Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancer
Prognostic Siginificance of FDG-PET in Patients with Limited Stage Small Cell Lung Cancer
Prognostic Siginificance of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Limited Stage Small Cell Lung Cancer
Prognostic Siginificance of FDG-PET in Patients with Limited Stage Small Cell Lung Cancer
Japan |
Limited Stage Small Cell Lung Cancer
Medicine in general | Pneumology | Hematology and clinical oncology |
Radiology | Laboratory medicine |
Malignancy
NO
To evaluate the prognostic siginificance of (18)F-fluorodeoxyglucose positron emission tomography in patients with limited-stage small-cell lung cancer who received 4 cycles of etoposide and cisplatin plus early concurrent accelerated hyperfractionated thoracic irradiation.
Efficacy
Overall survival
Progression free survival
Response rate
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
CDDP+VP-16 4 cycles
CDDP 80mg/m2 day1, VP-16 100mg/m2 day1-3
early concurrent twice-daily RT 1.5Gy 30fraction
20 | years-old | <= |
74 | years-old | >= |
Male and Female
1) cytologically, histologically proven small-cell lung cancer
2) limited disease except c-stage I
3) age 20-74 years old
4) performance status of 0-1
5) measurable disease
6) no prior treatment for small-cell lung cancer
7) no history of chemotherapy
8) adequate organ functions
9) written informed consent
1) pericardial effusion
2) active concomitant malignancy
3) pregnant or lactating women
4) interstitial pneumonia/active lung fibrosis on chest x-ray, watery diarrhea, intestinal obstruction or paralysis, uncontrolled heart disease or a history of myocardial infarction within the previous 6 months, uncontrolled diabetes mellitus, active infection, psychological disease deemed unacceptable for inclusion to the study, long-term steroid treatment.
38
1st name | |
Middle name | |
Last name | Yukito Ichinose |
National Kyushu Cancer Center
Department of Thoracic Oncology
Fukuoka
1st name | |
Middle name | |
Last name | Noriyuki Ebi |
Iizuka Hospital
Department of respiratory medicine
0948-22-3800
Lung Oncology Group in Kyushu, Japan (LOGIK)
Clinical Research Support Center kyushu
Non profit foundation
NO
2010 | Year | 10 | Month | 14 | Day |
Unpublished
Open public recruiting
2010 | Year | 09 | Month | 04 | Day |
2010 | Year | 09 | Month | 01 | Day |
2010 | Year | 10 | Month | 14 | Day |
2011 | Year | 11 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005217
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |